Healthpeak Properties, Inc. $DOC Shares Sold by Oppenheimer Asset Management Inc.

Key Points

• Oppenheimer Asset Management reduced its Healthpeak Properties stake by 10.9% in the second quarter, selling 114,416 shares and retaining 936,405 shares valued at approximately $20.0 million.
• Institutional investors and hedge funds own 93.57% of Healthpeak’s stock, with several major holders—including Norges Bank, UBS Asset Management and Bank of New York Mellon—recently increasing their positions.
• Healthpeak reported quarterly revenue of $771.6 million and EPS of $0.08, exceeding analyst estimates, while maintaining a monthly dividend of $0.1017 per share. Analysts’ consensus rating remains “Hold,” with an average price target of $21.44.

Oppenheimer Asset Management Inc. lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 10.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 936,405 shares of the real estate investment trust's stock after selling 114,416 shares during the quarter. Oppenheimer Asset Management Inc. owned about 0.14% of Healthpeak Properties worth $20,039,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank purchased a new position in Healthpeak Properties during the fourth quarter worth about $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Healthpeak Properties by 60.3% in the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock valued at $253,949,000 after purchasing an additional 5,815,189 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after buying an additional 4,776,056 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Healthpeak Properties by 214.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust's stock valued at $98,050,000 after buying an additional 2,883,382 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Trading Down 0.1%

Shares of DOC stock opened at $20.78 on Friday. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.95. The firm has a market cap of $14.33 billion, a PE ratio of 59.38, a price-to-earnings-growth ratio of 3.20 and a beta of 1.01. The company has a 50-day moving average of $21.33 and a two-hundred day moving average of $18.90. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same period in the previous year, the firm earned $0.46 EPS. The business's revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, analysts predict that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties's dividend payout ratio (DPR) is 348.57%.

Analysts Set New Price Targets

DOC has been the topic of several analyst reports. Raymond James Financial began coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They set a "market perform" rating on the stock. Wells Fargo & Company increased their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research report on Wednesday, July 15th. UBS Group raised their target price on Healthpeak Properties from $19.00 to $21.50 and gave the stock a "neutral" rating in a research note on Wednesday, July 8th. Cantor Fitzgerald lifted their target price on Healthpeak Properties from $20.00 to $23.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. Finally, Citigroup upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a research note on Tuesday. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $21.44.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source